Cheryl Gault
Chief Operating Officer · Rapport Therapeutics, Inc.
- 2025
- Oct 1, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Cheryl Gault files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Third Rock Ventures V, L.P. - $34.39M in RAPP purchases and sales in the last 12 months
- Abraham Ceesay - $5.93M in RAPP purchases and sales in the last 12 months
- Krishnaswamy Yeleswaram - $4.46M in RAPP purchases and sales in the last 12 months
- David Bredt - $1.14M in RAPP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Cheryl Gault?
Cheryl Gault is a corporate insider, tracked as Chief Operating Officer of Rapport Therapeutics, Inc. (RAPP). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Cheryl Gault submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Cheryl Gault been buying or selling stock?
Recorded transactions: 0 open-market purchases and 11 open-market sales ($1.43M) across all tracked filings.
